Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.

Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.

It is now well accepted that multipotent Bone-Marrow Mesenchymal Stem Cells (BM-MSC) contribute to cancer progression through several mechanisms including angiogenesis. However, their involvement during the lymphangiogenic process is poorly described. Using BM-MSC isolated from mice of two different...

Full description

Bibliographic Details
Main Authors: Ludovic Maertens, Charlotte Erpicum, Benoit Detry, Silvia Blacher, Bénédicte Lenoir, Oriane Carnet, Christel Péqueux, Didier Cataldo, Julie Lecomte, Jenny Paupert, Agnès Noel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4164522?pdf=render

Similar Items

Similar Items